Search Results 1571-1580 of 14728 for anti-TNF drugs

1. Dr. Mark Keegan Archives - Mayo Clinic News Network

   ... treatment options for MS. Also on the program, cardiologist Dr. Rekha Mankad explains why caution should be used when taking nonsteroidal anti-inflammatory ...

2. Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients Who Are PD-L1 Negative - Mayo Clinic

   Stereotactic body radiation therapy (SBRT) is a type of radiation therapy that uses high energy x-rays to kill tumor cells and shrink tumors. This method uses ...

3. Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Drugs used in chemotherapy, such as paclitaxel albumin-stabilized ... treatment (i.e. other investigational therapy, anti-neoplastic therapy, etc.) ...

4. Pneumococcal 20-Valent Conjugate Vaccine (Intramuscular Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

5. Filgrastim-Aafi (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   Descriptions. Filgrastim-aafi injection is used to treat neutropenia (low white blood cells) that is caused by cancer medicines. It is a synthetic ( ...

6. A Scientific Statement from the American Heart Association - Mayo Clinic News Network

   ... therapy. These drugs help prevent the formation of blood clots, which can cause heart attacks and strokes. The traditional approach is to prescribe ...

7. Fludeoxyglucose F 18 (Intravenous Route) Description and Brand Names - Mayo Clinic

   Fludeoxyglucose F 18 belongs to the group of medicines called radiopharmaceuticals (radioactive agents).

8. Prasugrel (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

9. Nivolumab and Brentuximab Vedotin After Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Classical Hodgkin Lymphoma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... Refractory to prior anti-PD-1/PD-L1 agent.

10. Timucin Taner, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    Focus areas · Liver transplant rejection. · Protective effect of liver transplant on other simultaneously transplanted organs. · Cell-based therapy to decrease ...